PitchCentric
Talking Points podcast artwork

science

Talking Points

Hosted by TCTMD · science · EN

Apple PodcastsWebsite

About this Podcast:

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.06f763f0-76e5-11f0-bb7c-8557ae1d8a8b

Pitch Analysis

Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Verified email

Booking probability

45%

Guest openness

Selective

Verified email on file
80/100
Required Score

Sign up to generate a grounded pitch for Talking Points.

Signup to Generate a Pitch

Questions about Talking Points

Who hosts Talking Points?

Talking Points is hosted by TCTMD. The show has published 213 episodes to date.

What has Talking Points covered recently?

Recent episodes include "The BHF PROTECT-TAVI Trial" (14 October 2026, 6 minutes), "The FAME 3 Trial" (16 September 2026, 9 minutes), and "The TRILUMINATE Pivotal Trial" (2 September 2026, 8 minutes).

How often does Talking Points publish?

Talking Points publishes roughly every two weeks, with episodes averaging 13 minutes across 213 episodes.

How hard is it to get booked on Talking Points?

Booking probability for Talking Points is 45%, and the host is rated Selective on guests. Talking Points requires a Pod Score of 80 or higher. Talking Points's contact route on record: verified email.

Who should pitch Talking Points?

The strongest fits for Talking Points are Doctors & Physicians. Talking Points has a science audience.

About the host

TCTMD hosts Talking Points, a science podcast with 213 episodes published.

Verified host email: ████████@████.comSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

View More
  • Talking Points

    The PROCTOR Trial

    Jun 3, 20269 min

    Ruben de Winter and C. Michael Gibson compare clinical outcomes of native vessel versus SVG PCI for patients with prior CABG.

  • May 20, 20265 min

    Christian M. Spaulding and C. Michael Gibson look at the 1-year results from the study comparing sirolimus-eluting DCB with DES for de novo coronary lesions.

  • Talking Points

    The VESALIUS-CV Trial

    May 6, 20267 min

    Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.

  • Talking Points

    The META-AF Trial

    Apr 22, 20265 min

    Amrish Deshmukh talks to C. Michael Gibson about the use of metformin as an adjunctive therapy to catheter ablation of AF.

  • Apr 1, 20268 min

    How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.

  • Talking Points

    The CorCMR Trial

    Mar 4, 20266 min

    Colin Berry and C. Michael Gibson discuss whether stress CMR imaging is helpful in patients with angina and no obstructive CAD.

  • Talking Points

    The TUXEDO-2 Trial

    Feb 4, 20264 min

    Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.

  • Talking Points

    The FLOW Trial

    Jan 7, 20266 min

    C. Michael Gibson talks to Katherine Tuttle about semaglutide's positive effects in patients with diabetes and chronic kidney disease.

  • Dec 17, 202516 min

    Mamas Mamas, Nieves Gonzalo, and Erick Schampaert take a look at the latest guidelines for chronic coronary syndromes and how they relate to complex PCI.

  • Dec 10, 20256 min

    Thomas Crawford meets with C. Michael Gibson to discuss the role of reconditioned pacemakers in low- and middle-income countries.

  • Dec 3, 202514 min

    Mamas Mamas, Birgitte Krogsgaard Andersen, and Niels Ramsing Holm discuss QFR versus FFR for guiding resvascularization in patients with coronary stenoses.

  • Talking Points

    The FLOW Trial

    Dec 3, 20256 min

    C. Michael Gibson talks to Katherine Tuttle about semaglutide's positive effects in patients with diabetes and chronic kidney disease.

  • Talking Points

    STORM-PE TRIAL

    Nov 19, 202514 min

    James Benenati, Robert Lookstein, and Rachel Rosovsky discuss the STORM-PE trial, the first-of-its-kind RCT for acute intermediate-high risk pulmonary embolism (PE).

  • Nov 12, 202515 min

    For patients with aortic stenosis, is earlier intervention beneficial? Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, and Bernard Prendergast discuss.

  • Talking Points

    The EPIC-CAD Trial

    Oct 29, 202514 min

    Mamas Mamas and Gi-byoung Nam discuss edoxaban monotherapy in patients with high-risk AF and stable CAD.

Recent guests

Recent guests on Talking Points. Study who booked and why before you pitch.

Best industries to pitch Talking Points for

PitchCentric classifies Talking Points under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.

Similar Podcasts

Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Podcasts like Talking Points

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

Questions about the free trial? See the pricing FAQ